ArticleFrontiers in immunology2026
Metabolic-immune crosstalk in head and neck squamous cell carcinoma: CD44 and APP identified as causal therapeutic targets via integrated lactylation-Mendelian randomization analysis.
Xi Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.